Decision expected on J&J vaccine
The CDC and FDA are leaning toward resuming the Johnson & Johnson vaccine after it was halted following reports of blood clots, sources told CBS News. Janet Shamlian has more.
Food and Drug Administration
U.S. COVID vaccination pace slows
A slowing pace of coronavirus vaccinations in the U.S. is fueling concerns that vaccine supply will soon exceed demand. As Janet Shamlian reports, efforts are lagging in the South and Midwest. Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University's Bloomberg School of Public Health, joined CBSN's Lana Zak to discuss the latest.
FDA cites "brown residue" and more at plant making J&J vaccine
Security footage showed peeling paint and workers carrying open bags of medical waste.
FDA orders J&J plant to stop vaccine production
The Food and Drug Administration has ordered one manufacturing plant to stop its production of Johnson & Johnson vaccine after contamination was found. Meanwhile, Dr. Anthony Fauci says he expects access to Johnson and Johnson doses to resume later this week. CBS News' Laura Podesta joins CBSN AM with an update.
Gottlieb says FDA could lift J&J pause with restrictions, warnings
Dr. Scott Gottlieb, the former FDA commissioner, says the pause on the single-dose vaccine could be lifted with additional restrictions on who should receive it, and warnings about potential side effects.
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired April 18, 2021, on "Face the Nation."
CDC extends Johnson & Johnson vaccine review
An emergency meeting of a Centers for Disease Control and Prevention advisory committee was held to discuss the extremely rare blood clots possibly associated with the Johnson and Johnson COVID-19 vaccine. The meeting ended without a decision on when the shots can be given again. CBS News' Laura Podesta joined "CBSN AM" with the latest.
Doctor discusses pause on use of Johnson & Johnson vaccine
The Centers for Disease Control and Prevention and the Food and Drug Administration say to stop administering Johnson & Johnson vaccines amid reports of six women who suffered from a rare blood clot days after receiving the company's vaccine. Dr. Dyan Hes, the founder of Gramercy Pediatrics in New York City, joins CBSN to discuss the latest on COVID-19.
Johnson and Johnson vaccine on hold
The Centers for Disease Control and Prevention are preparing to hold an emergency meeting Tuesday to discuss the pause on the Johnson and Johnson vaccine, due to six cases of rare but severe blood clots. All 50 states have temporarily stopped use of these shots. CBS News' Laura Podesta joins CBSN AM with the latest.
Johnson & Johnson vaccine paused nationwide
More than 7.2 million Americans have received the Johnson & Johnson COVID-19 vaccine and at least six of them developed serious blood clots. The CDC and FDA say the condition appears to be "extremely rare," but asked for the vaccine pause "out of an abundance of caution." Nancy Cordes reports.
U.S. recommends "pause" for Johnson & Johnson vaccine
The cases being investigated occurred in women between the ages of 18 and 48.
States halting use of Johnson & Johnson vaccine
All 50 states are halting use of Johnson and Johnson's coronavirus vaccine after at least six women developed blood clots. As CBS News' Jericka Duncan reports, the FDA and the CDC recommended a temporary pause to investigate these cases out of an "abundance of caution." Dr. Taison Bell, a critical care and infectious disease physician and the medical ICU director at the University of Virginia, joins CBSN's Elaine Quijano to discuss the latest.
FDA to propose limits on arsenic and lead in baby food
The Food and Drug Administration plans to propose limits on arsenic, lead and mercury in baby food, with the agency taking action two months after a congressional report found products from several of the country's largest manufacturers "tainted" with toxic heavy metals.
FDA to propose limits on arsenic and lead in baby food
Agency's plan comes two months after congressional report found toxic heavy metals in products for infants.
How big of a concern is the J&J clotting issue?
The Biden administration says that pausing the distribution of Johnson & Johnson's coronavirus vaccine should not hamper the nation's ongoing vaccine efforts. As CBS News' Skyler Henry reports, the announcement comes as the U.S. calls to pause the distribution of the Johnson & Johnson vaccine after receiving reports that at least six women had suffered a rare blood-clotting disorder after getting their shot. Dr. Julie Morita, a former member of the Biden administration transition advisory board and the executive vice president of the Rober Wood Johnson Foundation, joins CBSN's Tanya Rivero to discuss the impact the pause could have on the nation's vaccine efforts.
FDA calls for halt on Johnson & Johnson vaccine
The CDC and FDA have issued a joint statement recommending a pause in the use of the Johnson & Johnson COVID-19 vaccine in the United States. The agencies say they are reviewing six reported cases of a rare type of blood clot in people who have received the vaccine. Nearly 7 million doses have already been administered in the country.
Biden administration to lift abortion pill restriction amid pandemic
The FDA announced Monday evening that it would temporarily pause a medication abortion restriction that requires the pills to be dispensed in person.
Doctor weighs in on Johnson & Johnson pause
The CDC and FDA have issued a joint statement recommending a pause in the use of the Johnson and Johnson COVID-19 vaccine in the United States after six reports of blood clots in recipients. Nearly 7 million doses have been administered. Dr. David Agus joins "CBS This Morning" to discuss the developing facts Americans need to know.
U.S. recommends "pause" for Johnson & Johnson COVID vaccine
As of Monday over 6.8 million doses of the single-dose vaccine had been administered across the country.
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired April 11, 2021, on "Face the Nation."
Children are in the spotlight in the coronavirus battle
Pfizer wants to extend its COVID-19 vaccine to those as young as 12 years old and has asked the FDA for authorization to do that.
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired April 4, 2021, on "Face the Nation."
FDA warns against Real Water linked to hepatitis outbreak
Public urged against drinking recalled water brand still being sold online and promoted on social media.
Pfizer and BioNTech: Vaccine is 91% effective against COVID-19
Only a handful of people who got the drugmakers' vaccine contracted coronavirus, according to the latest trial.
The Label, Double Crossed, Made in China
Did the FDA ignite the opioid epidemic? Then, should a former terrorist be allowed into witness protection? And, China's drive to dominate the electric car industry
Trump promised to lower prices for Americans. Here's what the data shows.
Hurricane Isaias now a Category 3 storm as it threatens northern Gulf Coast
Interactive
These documents tell the story of the Cornell rape allegations
Pentagon's plan to livestream execution sparks intense backlash
Live
Iran's Houthi allies step up deadly attacks on Saudi Arabia
NYPD body camera footage shows aftermath of ICE agent shooting
Trump creates committee to investigate Fed's Lisa Cook
Nobel Peace Prize awarded to former ICC judge Navanethem "Navi" Pillay
Exclusive